Exploration of Potential Roles of a New LOXL2 Splicing Variant Using Network Knowledge in Esophageal Squamous Cell Carcinoma

LOXL2 (lysyl oxidase-like 2), an enzyme that catalyzes oxidative deamination of lysine residue, is upregulated in esophageal squamous cell carcinoma (ESCC). A LOXL2 splice variant LOXL2-e13 and its wild type were overexpressed in ESCC cells followed by microarray analyses. In this study, we explored...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wu, Bing-Li, Lv, Guo-Qing, Zou, Hai-Ying, Du, Ze-Peng, Wu, Jian-Yi, Zhang, Pi-Xian, Xu, Li-Yan, Li, En-Min
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4165399/
https://ncbi.nlm.nih.gov/pubmed/25254241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/431792
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires